Viviant 20mg Special Investigation (Regulatory Post Marketing Commitment Plan)
Phase of Trial: Phase IV
Latest Information Update: 30 Sep 2016
At a glance
- Drugs Bazedoxifene (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms VIOLINE
- Sponsors Pfizer
- 22 Sep 2016 Status changed from active, no longer recruiting to completed.
- 14 Mar 2016 Planned End Date changed from 1 Dec 2015 to 1 May 2016 as per ClinicalTrials.gov record.
- 14 Mar 2016 Planned primary completion date changed from 1 Dec 2015 to 1 May 2016 as per ClinicalTrials.gov record.